GlassScriptPhysician profile
Charles William Tate
NPI 1376583526
$11,768.06
in general payments reported to CMS, 2019-2025
17 companies · $3,952 in 2025
The $3,952 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $524 · 2020: $525 · 2021: $513 · 2022: $2,341 · 2023: $2,770 · 2024: $1,142 · 2025: $3,952.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,066 · Travel and Lodging: $1,798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,066.45 |
| Travel and Lodging | $1,798.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $3,661.95 | 2019-2025 | Carto 3, Qdot Micro Catheter, Nuvision Ice Catheter |
| Boston Scientific Corporation | $2,575.57 | 2019-2025 | Watchman Access System, Lux-Dx Insertable Cardiac Monitor, General - Therapies |
| Medtronic, INC. | $2,294.92 | 2021-2025 | Evera Mri Xt Dr Surescan, Aurora Ev-Icd Mri Surescan, Micra |
| Abbott Laboratories | $1,311.54 | 2019-2025 | Ensite Precision, Ensite, Perclose Prostyle |
| Impulse Dynamics (USA) INC. | $874.42 | 2023-2024 | Optimizer, Optimizer |
| Philips North America LLC | $252.95 | 2022-2025 | Ambulatory Monitoring & Diagnostics Undivided, (Ck4) Mcot, Extended Holter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $190.89 | 2022-2024 | Lifevest |
| Atricure, INC. | $165.02 | 2021-2022 | |
| Medtronic Vascular, INC. | $164.73 | 2019-2020 | |
| Cardiva Medical, INC. | $107.50 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Janssen Pharmaceuticals, INC | $36.56 | 2024 | Xarelto |
| Becton, Dickinson and Company | $26.53 | 2024 | Arista Ah Flexitip |
| Vital Connect, INC | $24.94 | 2025 | Vitalpatch Rtm |
| Heartflow, INC. | $24.06 | 2023 | Ffrct |
| Pfizer INC. | $23.84 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $18.21 | 2024 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $14.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Tate listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.